LifeStance director plans $1.78M share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. (LFST) director Kenneth A. Burdick reported an intended sale of 124,228 common shares, with an approximate sale date of November 16, 2026, and an aggregate market value of $1,778,017.78. He acquired the shares from the issuer on November 12, 2026, through a stock option exercise, paying cash. The notice names Fidelity Brokerage Services LLC as the broker and lists three prior sales by Kenneth Burdick: 66,589 shares on November 9 for $959,715.86; 75,000 shares on November 10 for $1,095,082.50; and 159,624 shares on November 12 for $2,284,844.97.
Key Figures
Key Terms
stock option exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.